STAT3 and prostate carcinoma: All in all, our exploration verified that LINC00473 contributes to cell proliferation via JAK-STAT3 signaling pathway by regulating miR-195-5p/SEPT2 axis in prostate cancer, presenting a possible solution for treating patients with prostate cancer.